Skip to main content

Table 3 Linear regression analysis to compare cardiac markers between sevoflurane and propofol for the subgroup with aortic valve surgery (n = 55)

From: Late pharmacologic conditioning with volatile anesthetics after cardiac surgery

Cardiac marker (U/L)

Unadjusted difference in means

(point estimate)

95% Cl

Adjusted difference in means

(point estimate)

95% CI

Troponin T, 4 hours (μg/L)

-0.5

-1.0, 0.0

-0.2

-0.4, 0.1

CK, 4 hours (U/L)

-146 a

-284, -8

-46

-146, 54

CK-MB, 4 hours (U/L)

-10.3

-25.1, 4.6

-1.3

-10.5, 7.7

Myoglobin, 4 hours (μg/L)

-60

-146, 27

4

-51, 58

Troponin T, POD1 (μg/L)

-0.5 a

-0.8, -0.1

-0.3 a

-0.6, -0.1

CK, POD1 (U/L)

-250 a

-497, -2

-120

-352, 112

CK-MB, POD1 (U/L)

-9.7

-21.7, 2.4

-4.8

-15.0, 5.4

Myoglobin, POD1 (μg/L)

-36

-141, 69

33

-47, 112

  1. 4 hours, 4 hours after ICU admission; creatine kinase; CK-MB, creatine kinase, heart muscle tissue;
  2. POD1, first postoperative day. The model is adjusted for age, blood products, baseline value of corresponding cardiac injury marker on ICU admission, and extracorporeal circulation (ECC) time. The propofol group is the reference. aP < 0.05, statistically significant.